ArticleFrontiers in aging2026
Inflammatory biomarkers and sarcopenia in older adults.
Article in Frontiers in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic inflammation contributes to the pathogenesis of sarcopenia in older adults. This study aimed to evaluate the correlation between inflammatory biomarkers such as C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and the anabolic hormone insulin-like growth factor-1 (IGF-1) with sarcopenia. A hospital-based case-control study was conducted among patients aged ≥60 years attending the Geriatric Medicine outpatient clinic. Participants were screened using the SARC-F tool and sarcopenia diagnosis was confirmed according to the Asian Working Group for Sarcopenia (AWGS) criteria. Serum levels of CRP, IL-6, TNF-α, and IGF-1 were measured using enzyme-linked immunosorbent assay (ELISA) in 30 sarcopenic cases and 30 age- and sex-matched controls. Group differences were assessed using independent samples t-test or Mann-Whitney U test, and correlations were evaluated using Spearman's rank correlation coefficient. The mean ages of cases and controls were 67.6 ± 7.5 and 66.1 ± 6.2 years, respectively; females comprised 56.7% of cases and 46.7% of controls. Mean CRP (5.58 ± 2.47 mg/L vs. 2.98 ± 3.00 mg/L;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.